Pacific Biosciences Of California (PACB) Income from Continuing Operations (2010 - 2026)

Pacific Biosciences Of California's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 8275000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 98.06% year-over-year to 8275000.0; the TTM figure through Mar 2026 stood at 128576000.0 (up 80.45% YoY), while the FY2025 annual figure was 546376000.0, down 76.34% from the prior year.
• Income from Continuing Operations was 8275000.0 for Q1 2026 at Pacific Biosciences Of California, up from 40371000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 2371000.0 in Q4 2024 to a low of 426075000.0 in Q1 2025.
• Historically, Income from Continuing Operations has averaged 87381470.59 across 5 years, with a median of 71394000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 102.89% in 2024, then tumbled 1802.7% in 2025.
• A 5-year view of Income from Continuing Operations shows it stood at 84384000.0 in 2022, then advanced by 2.8% to 82018000.0 in 2023, then surged by 102.89% to 2371000.0 in 2024, then sank by 1802.7% to 40371000.0 in 2025, then surged by 79.5% to 8275000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 8275000.0 (Q1 2026), 40371000.0 (Q4 2025), and 38000000.0 (Q3 2025), per Business Quant data.